Although many studies have supported the independent prognostic significance of CDKN2A/2B deletions in adult T-ALL [47,48], the spectrum of genomic heterogeneity in pediatric T-ALL has still not been fully explored [49,50,51]. The gene discussed is CDKN2A; the disease is acute lymphoblastic leukemia.